Dostarlimab with platinum-containing chemotherapy for treating primary advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair proficiency
Technology appraisal guidance
Reference number: TA1117
Published:
Evidence
Documents containing the evidence that was used to develop the recommendations.